{{Rsnum
|rsid=1923834
|Chromosome=13
|position=27786350
|Orientation=plus
|GMAF=0.1038
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 85.0 | 15.0 | 0.0
| HCB | 69.9 | 27.2 | 2.9
| JPT | 69.6 | 25.0 | 5.4
| YRI | 84.4 | 15.0 | 0.7
| ASW | 77.2 | 22.8 | 0.0
| CHB | 69.9 | 27.2 | 2.9
| CHD | 73.4 | 24.8 | 1.8
| GIH | 90.1 | 9.9 | 0.0
| LWK | 87.3 | 12.7 | 0.0
| MEX | 87.9 | 12.1 | 0.0
| MKK | 86.5 | 13.5 | 0.0
| TSI | 88.0 | 11.0 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=5E-6
  |OR=3.24
  |ORtxt=[1.823-5.744]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}